102 related articles for article (PubMed ID: 17259148)
1. [Effects of Alternanthera philoxeroides Griseb against respiratory syncytial virus infection in mice].
Jiang WL; Yang ZQ; Chen W; Xiao H; Luo XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):62-4. PubMed ID: 17259148
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of respiratory syncytial virus by intravenous gamma-globulin].
Li YH; Zhang GC; Xu DL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):640-2. PubMed ID: 16143076
[TBL] [Abstract][Full Text] [Related]
4. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Alternanthera philoxeroides Griseb against dengue virus in vitro].
Jiang WL; Luo XL; Kuang SJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):454-6. PubMed ID: 15837655
[TBL] [Abstract][Full Text] [Related]
7. Effects of norakin on respiratory syncytial virus in tissue culture and in mice.
Mentel R; Schroeder C; Döhner L
Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
9. DSCG reduces RSV-induced illness in RSV-infected mice.
Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
[TBL] [Abstract][Full Text] [Related]
10. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.
Lupfer C; Patton KM; Pastey MK
Toxicology; 2010 Jan; 268(1-2):25-30. PubMed ID: 19931343
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
13. [In vitro inhibitory mechanism of respiratory syncytial virus with solution prescription of zhidanhuayu].
Liu YH; Hou AC; Zhao GC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):486-7. PubMed ID: 19544654
[TBL] [Abstract][Full Text] [Related]
14. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of chikusetsusaponin IVa isolated from Alternanthera philoxeroides for its potency against viral replication.
Rattanathongkom A; Lee JB; Hayashi K; Sripanidkulchai BO; Kanchanapoom T; Hayashi T
Planta Med; 2009 Jun; 75(8):829-35. PubMed ID: 19277947
[TBL] [Abstract][Full Text] [Related]
16. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.
Blanco JC; Boukhvalova MS; Hemming P; Ottolini MG; Prince GA
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):945-55. PubMed ID: 16307507
[TBL] [Abstract][Full Text] [Related]
17. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Huang Y; Cyr SL; Burt DS; Anderson R
J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
[TBL] [Abstract][Full Text] [Related]
18. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
19. Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
Benoit AC; Huang Y; Maneewatchararangsri S; Tapchaisri P; Anderson R
Vaccine; 2007 Nov; 25(45):7754-62. PubMed ID: 17920164
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]